Ampliseq for Illumina Technology Enables Detailed Molecular Epidemiology of Rabies Lyssaviruses from Infected Formalin-Fixed Paraffin-Embedded Tissues

Viruses. 2022 Oct 12;14(10):2241. doi: 10.3390/v14102241.

Abstract

Whole genome sequencing of rabies lyssaviruses (RABVs) has enabled the generation of highly detailed phylogenies that reveal viral transmission patterns of disease in reservoir species. Such information is highly important for informing best practices with respect to wildlife rabies control. However, specimens available only as formalin fixed paraffin embedded (FFPE) samples have been recalcitrant to such analyses. Due to the damage inflicted by tissue processing, only relatively short amplicons can be generated by standard RT-PCR methods, making the generation of full-length genome sequences very tedious. While highly parallel shotgun sequencing of total RNA can potentially overcome these challenges, the low percentage of reads representative of the virus may be limiting. Ampliseq technology enables massively multiplex amplification of nucleic acids to produce large numbers of short PCR products. Such a strategy has been applied to the sequencing of entire viral genomes but its use for rabies virus analysis has not been reported previously. This study describes the generation of an Ampliseq for Illumina primer panel, which was designed based on the global sequence diversity of rabies viruses, and which enables efficient viral genome amplification and sequencing of rabies-positive FFPE samples. The subsequent use of such data for detailed phylogenetic analysis of the virus is demonstrated.

Keywords: formalin fixed tissues; phylogeny; rabies lyssavirus; viral lineage; viral typing.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Formaldehyde
  • Humans
  • Molecular Epidemiology
  • Nucleic Acids*
  • Paraffin Embedding
  • Phylogeny
  • RNA
  • Rabies virus* / genetics
  • Rabies* / epidemiology
  • Rabies* / veterinary
  • Technology

Substances

  • Formaldehyde
  • Nucleic Acids
  • RNA

Grants and funding

This research was supported by the Canadian Food Inspection Agency using funds provided to S.N.-D. from the Government of Canada’s Genomics Research and Development Initiative.